NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26, 2024 and will hold an.
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NovaBay Pharmaceuticals, Inc. announces a 64% increase in online subscription-based unit sales for its Avenova® Lid & Lash Spray Solution and a 38% increase in subscription-based customers in 2023.
Boulder-based Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA) has inked an agreement with NovaBay Pharmaceuticals Inc. (NYSE American: NBY) to jointly sell and market Avenova-branded products by Sonoma in the European Union.
Boulder s Sonoma to joint produce, market products in Europe – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.